Skip to main content
. 2020 May 24;17:73. doi: 10.1186/s12978-020-00923-w

Table 6.

Validation Results on Maternal and Newborn Outcome Quality Indicators in Northern Ethiopia (N = 455)

Indicators Women’s reported prevalence (%) True prevalence (%) Sensitivity of women’s self-report (95% CI) Specificity of women’s self-report (95% CI) Population survey estimate (Pr) AUC (95% CI) IF Criteria met
Maternal obstetric complication (yes to any) 18.68 14.95 45.59(33.45–58.12) 85.79(81.91–89.11) 17.90 0.65(0.61–0.70) 1.19 Both
Severe bleeding (hemorrhage) 9.67 8.35 28.95(15.42–45.90) 92.32(89.34–94.69) 9.46 0.60(0.53–0.66) 1.13 Both
Tear/laceration in vagina 3.96 3.52 50.0(24.65–75.35) 97.72(95.85–98.90) 3.96 0.74(0.69–0.78) 1.12 Both
Delays were not experienced during care 11.65 14.07 32.81(21.59–45.69) 91.82(88.64–94.33) 11.65 0.64(0.57–0.71) 0.83 Both
Birth asphyxia 8.13 6.81 64.52(12.76–64.86) 95.99(93.66–97.65) 8.13 0.76(0.68–0.84) 1.19 Both
Preeclampsia, eclampsia 5.93 3.96 38.89(17.30–64.25) 95.42 (93.02–97.18) 5.94 0.62(0.53–0.70) 1.50 AUC
Neonatal complication (yes to any) 17.36 12.53 64.91(51.10–77.10) 89.45(86.00–92.29) 14.34 0.71(0.65–0.76) 1.39 AUC
Newborn death within facility 1.98 4.18 10.53(1.30–33.14) 98.42(96.72–99.35) 1.95 0.60(0.45–0.73) 0.47 AUC
Still birth 6.37 4.18 26.32(9.15–51.20) 94.50(91.92–96.44) 6.37 0.57(0.50–0.64) 1.52 No

Notes: True prevalence indicates observers’ prevalence

Criteria Met - Indicator met either both AUC and IF, AUC only or IF only after validation analysis done

IF Inflation factor, AUC Area under receiver operating characteristic curve